{"id":"W4406030973","doi":"10.1021/acschembio.4c00450","title":"Functional Characterization of Pathway Inhibitors for the Ubiquitin-Proteasome System (UPS) as Tool Compounds for CRBN and VHL-Mediated Targeted Protein Degradation","year":2025,"lang":"en","type":"article","venue":"ACS Chemical Biology","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Janssen Canada; Genentech; Innovative Medicines Initiative; Deutsche Forschungsgemeinschaft; Structural Genomics Consortium; Takeda Foundation; Deutschen Konsortium für Translationale Krebsforschung; Ontario Genomics Institute; European Federation of Pharmaceutical Industries and Associations; Ontario Genomics; Genome Canada; Boehringer Ingelheim; McGill University; Bayer; Pfizer; Deutsches Krebsforschungszentrum; Bristol-Myers Squibb","keywords":"Ubiquitin; Proteasome; Protein degradation; Degradation (telecommunications); Ubiquitin-Protein Ligases; Chemistry; Cell biology; Cancer research; Ubiquitin ligase; Biology; Computational biology; Biochemistry; Computer science; Gene","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002619736,0.000156124,0.0001950038,0.00005257935,0.0001138896,0.00001721891,0.0001273806,0.0003057765,0.000004112686],"category_scores_gemma":[0.0006067005,0.0001191102,0.00008197743,0.0001196707,0.000154369,0.000008907532,0.00007730718,0.0000742437,0.00000131781],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002599894,"about_ca_system_score_gemma":0.0001102921,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006954608,"about_ca_topic_score_gemma":0.00000113288,"domain_scores_codex":[0.9989799,0.00005669709,0.000375771,0.0003337495,0.00006530091,0.0001886112],"domain_scores_gemma":[0.9992231,0.000109231,0.0001966778,0.0001916066,0.0002447635,0.00003458224],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003789309,0.00003583536,0.0001647426,0.0001124932,0.00006117122,4.640095e-8,0.000005605414,3.126446e-7,0.9904346,0.005828544,0.0003910623,0.002586646],"study_design_scores_gemma":[0.001055149,0.0002080272,0.0002852273,0.00003740966,0.0000208623,0.000002792948,0.00003462456,0.000181326,0.9762831,0.0002818666,0.02148331,0.0001263265],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9786239,0.000227565,0.01788512,0.0008596225,0.00025731,0.001816226,0.0002546375,0.00002758852,0.00004803596],"genre_scores_gemma":[0.9927225,0.00001735082,0.0004349009,0.0002676385,0.0002484157,0.001008907,0.004960411,0.00001371129,0.0003261434],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02109225,"threshold_uncertainty_score":0.4857171,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008583049878173842,"score_gpt":0.2283788089948934,"score_spread":0.2197957591167195,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}